OncoCyte Corp
NASDAQ:OCX

Watchlist Manager
OncoCyte Corp Logo
OncoCyte Corp
NASDAQ:OCX
Watchlist
Price: 3.16 USD -1.25% Market Closed
Market Cap: 90.4m USD

Intrinsic Value

The intrinsic value of one OCX stock under the Base Case scenario is 4.5 USD. Compared to the current market price of 3.16 USD, OncoCyte Corp is Undervalued by 30%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

OCX Intrinsic Value
4.5 USD
Undervaluation 30%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
OncoCyte Corp

What is Valuation History?
Compare OCX to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about OCX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about OncoCyte Corp
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
OncoCyte Corp

Current Assets 36.3m
Cash & Short-Term Investments 31m
Receivables 3.5m
Other Current Assets 1.7m
Non-Current Assets 24.1m
PP&E 7.2m
Intangibles 14.6m
Other Non-Current Assets 2.3m
Efficiency

Free Cash Flow Analysis
OncoCyte Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
OncoCyte Corp

Revenue
3.8m USD
Cost of Revenue
-1.8m USD
Gross Profit
2m USD
Operating Expenses
-18.7m USD
Operating Income
-16.7m USD
Other Expenses
-41.6m USD
Net Income
-58.3m USD
Fundamental Scores

OCX Profitability Score
Profitability Due Diligence

OncoCyte Corp's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

14/100
Profitability
Score

OncoCyte Corp's profitability score is 14/100. The higher the profitability score, the more profitable the company is.

OCX Solvency Score
Solvency Due Diligence

OncoCyte Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
49/100
Solvency
Score

OncoCyte Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

OCX Price Targets Summary
OncoCyte Corp

Wall Street analysts forecast OCX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OCX is 5.53 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

Lowest
Price Target
4.04 USD
28% Upside
Average
Price Target
5.53 USD
75% Upside
Highest
Price Target
8.4 USD
166% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

OncoCyte Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for OCX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

OCX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one OCX stock?

The intrinsic value of one OCX stock under the Base Case scenario is 4.5 USD.

Is OCX stock undervalued or overvalued?

Compared to the current market price of 3.16 USD, OncoCyte Corp is Undervalued by 30%.

Back to Top